BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 12075703)

  • 21. Surgical strategies and outcomes after induction therapy for non-small cell lung cancer.
    Burfeind WR; Harpole DH
    Semin Thorac Cardiovasc Surg; 2005; 17(3):186-90. PubMed ID: 16253820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complex and controversial issues in locally advanced non-small cell lung carcinoma.
    Machtay M; Jeremic B
    Semin Surg Oncol; 2003; 21(2):128-37. PubMed ID: 14508863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early-stage NSCLC: the role of radiotherapy and systemic therapy.
    Bunn PA
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S31-40. PubMed ID: 19780244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy for non-small-cell lung carcinoma: from a blanket approach to individual therapy.
    Reungwetwattana T; Eadens MJ; Molina JR
    Semin Respir Crit Care Med; 2011 Feb; 32(1):78-93. PubMed ID: 21500127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?
    Van Meerbeeck JP; De Pauw R; Tournoy K
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):199-206. PubMed ID: 18279061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Surgery and chemoradiation in stage IIIA non-small cell lung cancer].
    Hennequin C; Girard N; Mornex F
    Cancer Radiother; 2006 Nov; 10(6-7):477-83. PubMed ID: 17046307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant therapy for non-small cell lung cancer with mediastinal nodal involvement.
    Sanborn RE; Lally BE
    Thorac Surg Clin; 2008 Nov; 18(4):423-35. PubMed ID: 19086611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consensus conference: multimodality management of early- and intermediate-stage non-small cell lung cancer.
    Bordoni R
    Oncologist; 2008 Sep; 13(9):945-53. PubMed ID: 18779538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The study of peri-operative chemotherapy in stage I-IIIa NSCLC].
    Liao ML; Zhou YZ; Ding JA; Ni GX; Zhao JM; Chen WH; Han BH; Shen J; Bai H; Chen ZW; Ji H; Wang HM; Zhou Z
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):962-6. PubMed ID: 12899797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lung cancer].
    Nakagawa K; Kondo H
    Gan To Kagaku Ryoho; 2011 Sep; 38(9):1412-5. PubMed ID: 21918337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Early stages of non small cell lung cancer (I. II. IIIA). What is the best therapeutic strategy?].
    Riquet M; Berna P
    Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S36-16S42. PubMed ID: 17268334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant therapy of resected non-small-cell lung cancer.
    Socinski MA
    Clin Lung Cancer; 2004 Nov; 6(3):162-9. PubMed ID: 15555217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant therapy for lung cancer.
    Merk J; Leschber G
    Minerva Chir; 2009 Dec; 64(6):599-609. PubMed ID: 20029357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined-modality treatment of non-small-cell lung cancer stages I-III (take home messages).
    RĂ¼be C; Fleckenstein J
    Lung Cancer; 2004 Aug; 45 Suppl 2():S139-41. PubMed ID: 15552794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the prognostic role of a panel of biomarkers in stage IB-IIIA non-small cell lung cancer patients.
    Timotheadou E; Skarlos DV; Samantas E; Papadopoulos S; Murray S; Skrickova J; Christodoulou C; Papakostantinou C; Pectasides D; Papakostas P; Kaplanova J; Vrettou E; Karina M; Kosmidis P; Fountzilas G
    Anticancer Res; 2007; 27(6C):4481-9. PubMed ID: 18214064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of surgery in N2 non-small cell lung cancer.
    DeCamp MM; Ashiku S; Thurer R
    Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5033s-5037s. PubMed ID: 16000610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Non-small cell lung cancer (NSCLC): the evolution of neo-adjuvant chemotherapy in the last 15 years].
    Santo A; Genestreti G; Fiorio E; Terzi A; Lonardoni A; CalabrĂ² F; Campaldini B; Colaluca P; Molino A; Cetto GL
    Recenti Prog Med; 2006 Apr; 97(4):211-8. PubMed ID: 16729492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stage IIIA-N2 NSCLC: a review of its treatment approaches and future developments.
    van Meerbeeck JP; Surmont VF
    Lung Cancer; 2009 Sep; 65(3):257-67. PubMed ID: 19285751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Postoperative adjuvant therapy for 189 patients with completely resected non-small cell lung cancer of stage III(A)].
    Li Q; Gao JM; Liang PY; Xie FY; Liu GZ
    Ai Zheng; 2004 Nov; 23(11 Suppl):1463-6. PubMed ID: 15566658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prognostic factors and therapeutic strategy in non-small-cell bronchial carcinoma].
    Wolf M
    Praxis (Bern 1994); 1997 Oct; 86(42):1640-6. PubMed ID: 9432685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.